5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively

Haematologica. 2020 May;105(5):e213-e215. doi: 10.3324/haematol.2019.224030. Epub 2019 Sep 5.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers
  • Cytosine / analogs & derivatives
  • DNA-Binding Proteins / genetics
  • Dioxygenases
  • Humans
  • Mutation
  • Myelodysplastic Syndromes* / diagnosis
  • Myelodysplastic Syndromes* / genetics
  • Pentoxyl / analogs & derivatives
  • Phosphoproteins / genetics
  • Proto-Oncogene Proteins / genetics
  • RNA Splicing Factors / genetics

Substances

  • 5-formylcytosine
  • Biomarkers
  • DNA-Binding Proteins
  • Phosphoproteins
  • Proto-Oncogene Proteins
  • RNA Splicing Factors
  • SF3B1 protein, human
  • 5-hydroxymethyluracil
  • Pentoxyl
  • Cytosine
  • Dioxygenases
  • TET2 protein, human